Poewe WH - Search Results

1

Slower progression of Parkinson's disease with ropinirole versus levodopa: The REAL-PET study.

Whone AL, Watts RL, Stoessl AJ, Davis M, Reske S, Nahmias C, Lang AE, Rascol O, Ribeiro MJ, Remy P, Poewe WH, Hauser RA, Brooks DJ; REAL-PET Study Group. Whone AL, et al. Among authors: poewe wh. Ann Neurol. 2003 Jul;54(1):93-101. doi: 10.1002/ana.10609. Ann Neurol. 2003. PMID: 12838524 Clinical Trial.

2

Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.

Rascol O, Brooks DJ, Brunt ER, Korczyn AD, Poewe WH, Stocchi F. Rascol O, et al. Among authors: poewe wh. Mov Disord. 1998 Jan;13(1):39-45. doi: 10.1002/mds.870130111. Mov Disord. 1998. PMID: 9452324 Clinical Trial.

3

Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.

Korczyn AD, Brooks DJ, Brunt ER, Poewe WH, Rascol O, Stocchi F. Korczyn AD, et al. Among authors: poewe wh. Mov Disord. 1998 Jan;13(1):46-51. doi: 10.1002/mds.870130112. Mov Disord. 1998. PMID: 9452325 Clinical Trial.

4

The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.

Schrag AE, Brooks DJ, Brunt E, Fuell D, Korczyn A, Poewe W, Quinn NP, Rascol O, Stocchi F. Schrag AE, et al. Clin Neuropharmacol. 1998 May-Jun;21(3):169-75. Clin Neuropharmacol. 1998. PMID: 9617508 Clinical Trial.

5

Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial.

Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Salin L, Juhel N, Poewe W; Pramipexole ER Studies Group. Schapira AH, et al. Neurology. 2011 Aug 23;77(8):767-74. doi: 10.1212/WNL.0b013e31822affdb. Epub 2011 Aug 10. Neurology. 2011. PMID: 21832216 Clinical Trial.

6

Extended-release pramipexole in early Parkinson disease: a 33-week randomized controlled trial.

Poewe W, Rascol O, Barone P, Hauser RA, Mizuno Y, Haaksma M, Salin L, Juhel N, Schapira AH; Pramipexole ER Studies Group. Poewe W, et al. Neurology. 2011 Aug 23;77(8):759-66. doi: 10.1212/WNL.0b013e31822affb0. Epub 2011 Aug 10. Neurology. 2011. PMID: 21832218 Clinical Trial.

7

Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson's disease.

Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Debieuvre C, Fraessdorf M, Poewe W. Schapira AH, et al. Eur J Neurol. 2013 Jan;20(1):180-7. doi: 10.1111/j.1468-1331.2012.03822.x. Epub 2012 Jul 31. Eur J Neurol. 2013. PMID: 22845710 Clinical Trial.

8

Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson's disease.

Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Debieuvre C, Fraessdorf M, Poewe W; Pramipexole ER Studies Group. Schapira AH, et al. Eur J Neurol. 2013 Jan;20(1):50-6. doi: 10.1111/j.1468-1331.2012.03712.x. Epub 2012 Apr 27. Eur J Neurol. 2013. PMID: 22537207 Clinical Trial.

9

Long-term efficacy of opicapone in fluctuating Parkinson's disease patients: a pooled analysis of data from two phase 3 clinical trials and their open-label extensions.

Ferreira JJ, Lees A, Rocha JF, Poewe W, Rascol O, Soares-da-Silva P. Ferreira JJ, et al. Eur J Neurol. 2019 Jul;26(7):953-960. doi: 10.1111/ene.13914. Epub 2019 Mar 25. Eur J Neurol. 2019. PMID: 30681754 Free PMC article. Clinical Trial.

10

A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data.

Pagano G, Boess FG, Taylor KI, Ricci B, Mollenhauer B, Poewe W, Boulay A, Anzures-Cabrera J, Vogt A, Marchesi M, Post A, Nikolcheva T, Kinney GG, Zago WM, Ness DK, Svoboda H, Britschgi M, Ostrowitzki S, Simuni T, Marek K, Koller M, Sevigny J, Doody R, Fontoura P, Umbricht D, Bonni A; PASADENA Investigators; Prasinezumab Study Group. Pagano G, et al. Front Neurol. 2021 Oct 1;12:705407. doi: 10.3389/fneur.2021.705407. eCollection 2021. Front Neurol. 2021. PMID: 34659081 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

303 results

Search Page

Filters